{"DataElement":{"publicId":"14007909","version":"1","preferredName":"Agent Substitution Administered Reason","preferredDefinition":"An explanation that describes why the agent was substituted.","longName":"AGNT_SUB_ADMIN_RSN","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"14007901","version":"1","preferredName":"Agent Substitution Administered","preferredDefinition":"A medication was substituted with another.:The act of having given something (e.g., a medication or test).","longName":"14007900v1.00:2233610v1.00","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"14007900","version":"1","preferredName":"Agent Substitution","preferredDefinition":"A medication was substituted with another.","longName":"C185634","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent Substitution","conceptCode":"C185634","definition":"A medication was substituted with another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF36FD57-1938-276E-E053-731AD00ABB20","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF36FD57-1939-276E-E053-731AD00ABB20","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":"2023.9.12 Released per review. ak2023.6.28 Created per ticket request CADSR0002550. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14007904","version":"1","preferredName":"Agent Substitution Reason","preferredDefinition":"A medication was substituted with another._An explanation of the cause of some phenomenon or action.","longName":"14007904v1.00","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Allergic reaction","valueDescription":null,"ValueMeaning":{"publicId":"7351128","version":"1","preferredName":"Allergic Reaction","longName":"7351128","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA4C3B35-FE6E-3C61-E053-4EBD850A29C2","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"DWARZEL","dateCreated":"2020-07-13","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF371824-6C00-2D76-E053-731AD00A93DD","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"Silent inactivation","valueDescription":null,"ValueMeaning":{"publicId":"14007906","version":"1","preferredName":"Silent Inactivation","longName":"14007906v1.00","preferredDefinition":"The development of asparaginase inactivity due to asparaginase antibodies in the absence of overt or recognized allergy symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Silent Inactivation","conceptCode":"C200300","definition":"The development of asparaginase inactivity due to asparaginase antibodies in the absence of overt or recognized allergy symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF371824-6BFE-2D76-E053-731AD00A93DD","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF371824-6C01-2D76-E053-731AD00A93DD","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"Drug shortage","valueDescription":null,"ValueMeaning":{"publicId":"14007907","version":"1","preferredName":"Drug Shortage","longName":"14007907v1.00","preferredDefinition":"A deficit in the availability of a pharmaceutical agent because the supply is insufficient to meet the actual or predicted therapeutic demand.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Shortage","conceptCode":"C134968","definition":"A deficit in the availability of a pharmaceutical agent because the supply is insufficient to meet the actual or predicted therapeutic demand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF371824-6BFF-2D76-E053-731AD00A93DD","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF371824-6C02-2D76-E053-731AD00A93DD","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF371824-6C03-2D76-E053-731AD00A93DD","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"14007903","version":"1","preferredName":"Agent Substitution Reason","preferredDefinition":"A medication was substituted with another._An explanation of the cause of some phenomenon or action.","longName":"14007903v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent Substitution","conceptCode":"C185634","definition":"A medication was substituted with another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF370652-2424-2BCF-E053-731AD00A795F","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF370652-2425-2BCF-E053-731AD00A795F","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":"2023.9.12 Released per review. ak 2023.6.28 Created per ticket request CADSR0002550. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Why was the agent substituted?","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"What was reason for substitution of Erwinia product rather than Calaspargase pegol-MKNL (Asparlas)?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF372F8C-1058-2FE0-E053-731AD00AA006","latestVersionIndicator":"Yes","beginDate":"2023-06-28","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-06-28","modifiedBy":"KUMMEROA","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":"2023.9.12 Released per metrics report. ak2023.6.28 Created per ticket request CADSR0002550. ak","unresolvedIssues":null,"deletedIndicator":"No"}}